Skip to main content

REVIEW article

Front. Cell Dev. Biol., 12 July 2021
Sec. Molecular and Cellular Oncology
Volume 9 - 2021 | https://doi.org/10.3389/fcell.2021.686453

RETRACTED: Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy

Retracted

A retraction of this article was approved in:

  1. Retraction: Mesenchymal stem/stromal cell-based delivery: a rapidly evolving strategy for cancer therapy

    1. Read retraction
\r\nAli Hassanzadeh Amjad Hussein Altajer Heshu Sulaiman Rahman, Marwan Mahmood Saleh Dmitry O. Bokov Walid Kamal Abdelbasset, Faroogh Marofi Majid Zamani Yoda Yaghoubi Mahboubeh Yazdanifar Yashwant Pathak, Max Stanley Chartrand Mostafa Jarahian*Ali Hassanzadeh1 Amjad Hussein Altajer2 Heshu Sulaiman Rahman3,4 Marwan Mahmood Saleh5 Dmitry O. Bokov6 Walid Kamal Abdelbasset7,8 Faroogh Marofi9 Majid Zamani10 Yoda Yaghoubi11 Mahboubeh Yazdanifar12 Yashwant Pathak13,14 Max Stanley Chartrand15 Mostafa Jarahian16*
  • 1Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • 2Department of Pharmaceutics, College of Pharmacy, Almaaqal University, Basra, Iraq
  • 3College of Medicine, University of Sulaimani, Sulaymaniyah, Iraq
  • 4Department of Medical Laboratory Sciences, Komar University of Science and Technology, Sulaymaniyah, Iraq
  • 5Department of Biophysics, College of Applied Sciences, University of Anbar, Ramadi, Iraq
  • 6Sechenov First Moscow State Medical University, Moscow, Russia
  • 7Department of Health and Rehabilitation Sciences, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al Kharj, Saudi Arabia
  • 8Department of Physical Therapy, Kasr Al-Aini Hospital, Cairo University, Giza, Egypt
  • 9Immunology Research Center (IRC), Tabriz University of Medical Sciences, Tabriz, Iran
  • 10Department of Medical Laboratory Sciences, Faculty of Allied Medicine, Gonabad University of Medical Sciences, Gonabad, Iran
  • 11Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  • 12Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, United States
  • 13Professor and Associate Dean for Faculty Affairs, Taneja College of Pharmacy, University of South Florida, Tampa, FL, United States
  • 14Adjunct Professor, Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia
  • 15DigiCare Behavioral Research, Casa Grande, AZ, United States
  • 16German Cancer Research Center, Toxicology and Chemotherapy Unit (G401), Heidelberg, Germany

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Hassanzadeh A, Altajer AH, Rahman HS, Saleh MM, Bokov DO, Abdelbasset WK, Marofi F, Zamani M, Yaghoubi Y, Yazdanifar M, Pathak Y, Chartrand MS and Jarahian M (2021) Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy. Front. Cell Dev. Biol. 9:686453. doi: 10.3389/fcell.2021.686453

Received: 26 March 2021; Accepted: 10 June 2021;
Published: 12 July 2021; Retracted: 04 September 2023.

Edited by:

Luisa Lanfrancone, European Institute of Oncology (IEO), Italy

Reviewed by:

Elisabetta Manuela Foppiani, Emory University, United States
Juliano Andreoli Miyake, Federal University of Santa Catarina, Brazil

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.